- Hoya’s net income in Q4 was 57.09 billion yen, a year-on-year increase of 34%, which surpassed the estimated 47.13 billion yen.
- Net sales reached 196.82 billion yen, 6% higher than the previous year, outdoing the projected 194.08 billion yen.
- Life Care revenue grew by 9.7% from the previous year to 137.03 billion yen, slightly more than the estimated 136.76 billion yen.
- Health care related products brought in 102.60 billion yen, a growth of 11% over the same period last year, marginally above the estimated 101.59 billion yen.
- Medical related products made a revenue of 34.43 billion yen, an increase of 6.2% from the previous year, but underperforming slightly against the estimated 35.92 billion yen.
- Information Technology revenue slipped by 1.5% from last year to 58.74 billion yen, though it still beat the expected figure of 55.17 billion yen.
- There was a 4.9% decrease in revenue from Electronics related products compared to last year, making 48.90 billion yen, but still managed to surpass the expected 46.38 billion yen.
- Imaging related products saw a significant 20% rise in revenue to 9.84 billion yen compared to the previous year, considerably more than the estimated 8.79 billion yen.
- Currently, the company has more buyers with 13 buy ratings, 3 hold ratings, and only 1 sell rating.
- All comparisons to past results are based on values reported by from the company’s original disclosures.
A look at Hoya Corp Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 5 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts at Smartkarma have pegged Hoya Corp‘s long-term outlook as positive, largely due to its strong performance in growth and resilience. With a score of 4 in growth and 5 in resilience, the company is positioned to expand its operations and navigate challenges effectively. While the value and dividend scores are middling at 2 each, the high marks in growth and resilience suggest that Hoya Corp is well-equipped to weather uncertainties and capitalize on opportunities in the market.
Hoya Corp, a manufacturer of electro-optics products ranging from semiconductors to medical endoscopes, is backed by a solid overall Smartkarma Smart Score of 3. With strengths in growth and resilience, the company shows promise for long-term sustainability and competitiveness. This indicates that despite average ratings in value and dividend, Hoya Corp‘s focus on innovation and ability to withstand disruptions positions it favorably for future growth and performance in the industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
